The global Needle-Free Injectors Market is on track for substantial growth, with a 12% year-over-year (Y-o-Y) increase, projected to reach USD 42.79 billion by 2032, according to recent market research. This growth is primarily driven by the increasing focus on advanced treatment methods, the rise in chronic diseases, and the demand for efficient, needle-free delivery systems in healthcare.
The growing global emphasis on innovative healthcare solutions is a key factor propelling the demand for needle-free injectors. Pharmaceutical companies are introducing advanced products to address rising concerns over disease transmission, ensuring greater safety and convenience for both patients and healthcare providers. The shift towards needle-free injectors has gained momentum due to the ease of use, reduced risk of needle-stick injuries, and increased patient comfort, making them ideal for chronic disease management and long-term treatments.
Further supporting this growth is the adoption of advanced materials in manufacturing needle-free injectors, enhancing their effectiveness in delivering medications, especially for chronic conditions such as diabetes, arthritis, and multiple sclerosis. These innovations are opening up new growth opportunities in the global healthcare market, particularly as pharmaceutical companies focus on creating safer, more efficient treatment options.
Despite these advantages, challenges related to high manufacturing costs and the limitations of large-volume, intravenous administration systems may hinder market progress. Additionally, from 2020 to 2022, the market faced limitations due to the onset of transmittable diseases, which temporarily disrupted the demand for needle-free injectors. However, with the evolving healthcare landscape and the increasing emphasis on patient safety and comfort, the needle-free injectors market is set to overcome these barriers and experience significant growth in the coming years.
Key Takeaways:
- Market Growth: The needle-free injectors market is expected to grow at a 12% Y-o-Y growth rate, reaching USD 42.79 billion by 2032.
- Healthcare Innovation: Advanced treatment approaches and needle-free systems are driving the adoption of these devices in chronic disease management.
- Increased Demand for Safety: Rising cases of disease transmission and the need for safe, efficient delivery systems have spurred pharma companies to introduce quality needle-free injectors.
- Challenges: High manufacturing costs and limitations with large volume injections pose challenges to market growth, though these are expected to be mitigated with technological advancements.
- Pandemic Impact: From 2020 to 2022, the market faced a temporary decline due to the global focus on transmittable diseases, though demand is expected to surge moving forward.
The needle-free injectors market is poised to play a crucial role in the future of chronic disease treatment, providing patients with a more comfortable and safe method of drug delivery.
Key Growth Drivers
- Emphasis on Advanced Treatment Approaches: There is a growing focus on effective and innovative treatment methods, which is driving sales of needle-free injectors as they offer a non-invasive alternative to traditional needles.
- Increase in Disease Transmission Cases: The rise in cases of diseases transmitted through conventional injection methods has compelled pharmaceutical companies to develop and introduce high-quality needle-free products that enhance safety and reduce the risk of infection.
- Use of Advanced Materials: The incorporation of advanced materials in the manufacturing of needle-free injectors, particularly for chronic disease treatments, is expected to provide robust growth prospects. These materials improve the efficacy and comfort of drug delivery.
Market Challenges
Despite the advantages, there are limitations that could impede market growth:
- Higher Manufacturing Costs: The production costs associated with needle-free injectors can be higher compared to traditional injection systems, which may affect pricing and accessibility.
- Limitations with Large Volume and Intravenous Administration: Current designs may not be suitable for administering larger volumes or for intravenous applications, which can limit their use in certain medical scenarios.
Start-Up For Needle-Free Injectors Market
Few key players in the needle-free injectors market are Portal Instruments and NovaXS Biotech.
- In March 2022, NovaXS Biotech has received investor support for its patented needle-free injector. The device possesses a cloud-based platform that collects patient information for physicians. Information such as injection time, frequency, dosage volume, and medication temperature are expected to help the physicians to understand the effects of the dosage on the patient.
- Portal Instruments, a key player in the needle-free injectors is focusing on commercializing its needle-free injectors. Thus, the company is focusing on collaborating with different established needle-free injectors.
Market Competition
Key players in the needle-free injectors market are Gerresheimer AG, Pfizer Inc., Halozyme, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation
Key players are focusing on the expansion of their brands in emerging regions and manufacturing the newly revised product. Manufacturers are also adopting a slew of expansion strategies such as acquisition, new product launches and approvals, agreements, partnerships, and collaborations to strengthen their market presence.
- In August 2022, PharmaJet was selected by WHO for million+ polio vaccination campaigns in Pakistan. Through this, the company will provide needle-free vaccines to 2.7 million children.
- In May 2022, Gerresheimer AG and Portal Instruments entered a strategic partnership to treat chronically ill patients with innovative needle-free drug delivery solution. Together the companies are focusing on offering painless experience of injections to patients.
A Full Report Overview
Key Segments Profiled In The Needle-Free Injectors Market Industry Survey
By Load:
- Needle-Free Injectors by Liquid Injections
- Needle-Free Injectors by Powder Injections
- Needle-Free Injectors by Projectile Injections
By Technology:
- Needle-Free Injectors by Spring-loaded jet injector
- Needle-Free Injectors by Battery-powered jet injector
- Needle-Free Injectors by Gas-powered jet injector
By Delivery Site:
- Needle-Free Injectors by Intra dermal injectors
- Needle-Free Injectors by Intramuscular injectors
- Needle-Free Injectors by Subcutaneous injectors
By Application:
- Needle-Free Injectors by Drug Delivery
- Needle-Free Injectors by Vaccines
- Needle-Free Injectors by Cosmetic
- Needle-Free Injectors by Others
By End User:
- Needle-Free Injectors by Home Care Settings
- Needle-Free Injectors by Long Term Care Centers
By Region:
- North America Needle-Free Injectors Market
- Latin America Needle-Free Injectors Market
- Europe Needle-Free Injectors Market
- East Asia Needle-Free Injectors Market
- South Asia Needle-Free Injectors Market
- Oceania Needle-Free Injectors Market
- Middle East & Africa Needle-Free Injectors Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube